CATX
Perspective Therapeutics Inc.
NYSE MKT: CATX · HEALTHCARE · MEDICAL DEVICES
$3.90
-0.89% today
Updated 2026-04-30
Market cap
$514.22M
P/E ratio
—
P/S ratio
581.70x
EPS (TTM)
$-1.41
Dividend yield
—
52W range
$2 – $6
Volume
1.6M
Perspective Therapeutics Inc. (CATX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$3.90
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.